Optimising Exercise Prescription For Brain Health In Older Adults At Risk Of Dementia
Funder
National Health and Medical Research Council
Funding Amount
$594,123.00
Summary
To reduce dementia burdens in the community, cost effective and targeted early regenerative strategies are critical. Engaging in frequent aerobic exercise is one strategy that can delay the onset and slow the progression of dementia. However, prescription is limited by an incomplete understanding of how exercise positively influences brain health. Here I will investigate the influence of current exercise levels, intensity and exercise environment on brain health in adults at risk of dementia.
Psychosis contributes significantly to global disease burden, affecting more than 3% of the population when schizophrenia, schizoaffective disorder, and bipolar disorders are considered together. These conditions aggregate within families, and genetic risk factors do not conform to traditional diagnostic categories. My work employs brain-based classification techniques to derive subtypes of psychosis that dissect, and/or span the diagnostic categories, for investigation of modifiable genetic and ....Psychosis contributes significantly to global disease burden, affecting more than 3% of the population when schizophrenia, schizoaffective disorder, and bipolar disorders are considered together. These conditions aggregate within families, and genetic risk factors do not conform to traditional diagnostic categories. My work employs brain-based classification techniques to derive subtypes of psychosis that dissect, and/or span the diagnostic categories, for investigation of modifiable genetic and environmental risk factors for psychosis.Read moreRead less
Dementia Related Deficits In Striatal Cholinergic Function And Decision-making
Funder
National Health and Medical Research Council
Funding Amount
$414,370.00
Summary
This proposal will provide essential new information on the role of deficits in decision-making associated with Parkinson’s disease dementia. We will use an innovative animal model to assess the influence of neurodegeneration and neuroinflammation the consequent loss of function in the neuronal systems supporting the learning and memory processes that contribute to goal-directed action, particularly the way new learning interacts with existing memory to guide choice and decision-making.
Neuronal Activity And Functional Magnetic Resonance Imaging (fMRI)
Funder
National Health and Medical Research Council
Funding Amount
$367,561.00
Summary
How does brain activity relate to perception and behaviour? How does functional magnetic resonance imaging (fMRI) of the brain, which measures changes in blood oxygen, relate to the activity of single cells? I will address these questions, comparing electrical measurements of single cells and functional images, and advance our understanding of the brain in health and disease.
The amygdala is a part of the brain that processes and lays down emotional memories. Dysfunction in the amygdala is responsible for anxiety related disorders such post-traumatic stress disorder. I will study the neural circuits in the amygdala using innovative recordings and stimulation techniques. These studies will provide insight into the circuits that underpin anxiety related neurological disorders and provide targets for development of novel anxiolytic agents.
A Systematic Evaluation Of The Neurosurgical Application Of Peri-operative And Intra-operative MR Tractography In Different Paediatric Disease States
Funder
National Health and Medical Research Council
Funding Amount
$130,910.00
Summary
My research investigates changes in brain nerve fibre tracts/white matter in paediatric disease states and changes related to surgery by using nerve fibre tract imaging before, during and after surgery. It will also generate an imaging atlas to help understand white matter pathway development. It then serves as normative comparison to better understand aberrations in diseased neural pathways. The outcome will aid understanding in brain development, recovery and plasticity, and helps improve whit ....My research investigates changes in brain nerve fibre tracts/white matter in paediatric disease states and changes related to surgery by using nerve fibre tract imaging before, during and after surgery. It will also generate an imaging atlas to help understand white matter pathway development. It then serves as normative comparison to better understand aberrations in diseased neural pathways. The outcome will aid understanding in brain development, recovery and plasticity, and helps improve white matter lesion localisation.Read moreRead less
Protecting Synaptic Connectivity In Alzheimer's Disease
Funder
National Health and Medical Research Council
Funding Amount
$573,573.00
Summary
In Alzheimer’s disease, connections between neurons (synapses) are progressively damaged. The BACE inhibitor class of drugs entering Phase III clinical trials may slow the pace of neurodegeneration in patients with dementia. However, these drugs may simultaneously have negative effects on synapse function, learning and memory. This study will assess the effect of BACE inhibition on synapse properties and cognition and identify the contribution of key proteins affected by this treatment.
Development Of Novel Biomarkers For Closed Loop Deep Brain Stimulation In The Management Of Parkinson’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$124,676.00
Summary
Deep Brain Stimulation (DBS) is established therapy in advanced Parkinson’s disease, when medications are less efficient. We aim to identify biomarkers that correlate with symptom state, allowing tailoring of DBS to individual patient’s needs. This will potentially improve symptom control, device efficiency and quality of life, increasing the pool of patients suitable for DBS. Novel DBS systems will build technical expertise and expand Australia’s role in the medical device industry.
Thrombolysis is a method of dissolving the blood clot that is the cause of the majority of strokes in Australia. The first major trial to demonstrate benefit for this treatment was published some 11 years ago but treatment has not been widely implemented across Australia because of the difficulties in giving treatment within the very tight time window for which treatment is currently approved (patients must get to hospital, be scanned and start treatment within 3 hours of the onset of the stroke ....Thrombolysis is a method of dissolving the blood clot that is the cause of the majority of strokes in Australia. The first major trial to demonstrate benefit for this treatment was published some 11 years ago but treatment has not been widely implemented across Australia because of the difficulties in giving treatment within the very tight time window for which treatment is currently approved (patients must get to hospital, be scanned and start treatment within 3 hours of the onset of the stroke). Other factors which have limited implementation of treatment in Australia are continued debate over the trial data for this treatment as only one of the 5 major trials was positive. In addition, virtually no patients aged over 80 years old were included in the previous trials, and as this age group represents about a third of all stroke in Australia, new data in this age group is required. As a result of the difficulty in giving a treatment within such a tight time window and the ongoing debate about the trial data, few Australians are currently treated and thus the public health impact is negligible. In to change clinical practice, we need reliable data from a large convincing further trial of thrombolysis with the more realistic time window of 6 hours. The Third International Stroke Trial (IST-3) is a large international collaborative effort to determine whether thrombolysis treatment offered to a wider range of patients up to 6 hours from stroke onset results in an increase in long-term independent survival. Data from such a trial is most likely to change clinical practice and lead to an important public health benefit.Read moreRead less